Trial of Kuvan in Lesch-Nyhan Disease

Trial of Kuvan™ (Sapropterin) Treatment in Patients With Lesch Nyhan Disease

NCT00935753•University of California, San Diego

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Behavioral Manifestations of Lesch-Nyhan Disease

Interventions

sapropterin

Locations

United States

Locations (1)

UCSD Mitochondrial and Metabolic Disease Center

San Diego, California, United States

Key Dates

Start Date

April 1, 2009

Primary Completion Date

February 1, 2010

Completion Date

February 1, 2010

Last Updated

August 2, 2019

Sponsors

Lead Sponsor

University of California, San Diego

Collaborators

BioMarin Pharmaceutical

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions